Dr. James M. Love M.D.

Recommended Articles

• Literally Fighting Parkinson's: Fitness Program Focuses on Boxing to Alleviate Symptoms

  “Exercise is good for the brain” is a statement largely supported by scientists, physicians, researchers and all kinds of experts in the field of neurology. Some of the benefits the brain can receive from regular exercise are:...

• New Multiple Sclerosis Treatment, Ocrevus, Slows Down Disease Progression

  In 2017, the United States Food and Drug Administration (USFDA) approved the drug – Ocrevus (ocrelizumab) – as a treatment for both relapsing and progressive forms of multiple sclerosis. ...

• The Signs of Stroke in Women

  Stroke is found to be the third leading cause of death in women around the world. As women generally live longer than men, the effects of a stroke affect women more than men. Women also live longer in a healthcare facility after having a stroke than men do. Women are more prone to a stroke...

• Sarepta Sheds Light on Next Generation Drug for Muscular Dystrophy Patients

  Each company has faced its own set of issues, with Sarepta being one of many that are trying to make amends for some issues that have happened in the past. Although there happened to be some issues with the data that was coming from Sarepta, their approval of the drug that can assist with muscular...

• One Step Closer to a Cure: New Developments in Parkinson’s Research

  Parkinson's disease is a neurodegenerative disease that affects a lot of people worldwide with an estimated figure of about 1 million in the United States alone, according to the National Parkinson’s Foundation. Despite the sheer amount of support available for patients as seen in the dozens of...

• Improving Sleep Apnea Symptoms May Benefit Epilepsy Patients

  Epilepsy affects approximately 0.5-1 percent of the population. It is a disease characterized by involuntary movements or seizures. Although numerous drugs have been introduced to treat epilepsy over the last few decades, almost one-third of those living with epilepsy do not benefit from these...